Skip to Main Content

Paper Details

The long tail of oncogenic drivers in prostate cancer.
Nat Genet
525
2018
E26 transformation, E26 transformation-specific (ETS)-fusion-negative tumors, ETS, PI3K, SMGs, SPEN, androgen, genomic markers, primary and metastatic prostate cancer, prostate cancer, prostate cancers, recurrently mutated genes, significantly mutated genes, ubiquitin ligase CUL3
Author NameAffiliation
Joshua ArmeniaMemorial Sloan Kettering Cancer Center
Joshua ArmeniaMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Stephanie A WankowiczDana-Farber Cancer Institute
Stephanie A WankowiczBroad Institute of MIT and Harvard
Jianjiong GaoMemorial Sloan Kettering Cancer Center
Jianjiong GaoMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Jianjiong GaoMemorial Sloan Kettering Cancer Center
Jianjiong GaoMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Ritika KundraMemorial Sloan Kettering Cancer Center
Ritika KundraMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Walid K ChatilaMemorial Sloan Kettering Cancer Center
Walid K ChatilaMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Debyani ChakravartyMemorial Sloan Kettering Cancer Center
Debyani ChakravartyMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Ilsa ColemanDivisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center
Bruce MontgomeryUniversity of Washington
Colin C PritchardUniversity of Washington
Colm MorrisseyUniversity of Washington
Christopher E Barbieri
Christopher E Barbieri
Himisha Beltran
Himisha BeltranSandra and Edward Meyer Cancer Center at Weill Cornell Medical College
Himisha BeltranEnglander Institute for Precision Medicine, Weill Cornell Medical College-New York Presbyterian Hospital
Himisha Beltran
Himisha BeltranSandra and Edward Meyer Cancer Center at Weill Cornell Medical College
Himisha BeltranEnglander Institute for Precision Medicine, Weill Cornell Medical College-New York Presbyterian Hospital
Andrea Sboner
Andrea Sboner
Zafeiris ZafeiriouDivision of Clinical Studies, The Institute of Cancer Research and Royal Marsden Hospital
Susana MirandaDivision of Clinical Studies, The Institute of Cancer Research and Royal Marsden Hospital
Franklin W HuangDana-Farber Cancer Institute
Franklin W HuangBroad Institute of MIT and Harvard
Franklin W HuangDana-Farber Cancer Institute
Franklin W HuangBroad Institute of MIT and Harvard
Dan R RobinsonMichigan Center for Translational Pathology, University of Michigan ann arbor
Yi-Mi WuMichigan Center for Translational Pathology, University of Michigan ann arbor
Robert J LonigroMichigan Center for Translational Pathology, University of Michigan ann arbor
Levi A GarrawayDana-Farber Cancer Institute
Levi A GarrawayBroad Institute of MIT and Harvard
Levi A GarrawayDana-Farber Cancer Institute
Levi A GarrawayBroad Institute of MIT and Harvard
Francesca DemichelisUniversity of Trento
Francesca DemichelisUniversity of Trento
Philip W KantoffMemorial Sloan Kettering Cancer Center
Philip W KantoffMemorial Sloan Kettering Cancer Center
Mary-Ellen TaplinDana-Farber Cancer Institute
Wassim AbidaMemorial Sloan Kettering Cancer Center
Barry S TaylorMemorial Sloan Kettering Cancer Center
Barry S TaylorMemorial Sloan Kettering Cancer Center
Barry S TaylorMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
  • 1 - 50

Datasets